Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$331M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$324M |
| 3 |
Salesforce
CRM
|
+$301M |
| 4 |
Adobe
ADBE
|
+$294M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$422M |
| 2 |
Lloyds Banking Group
LYG
|
+$252M |
| 3 |
Barclays
BCS
|
+$135M |
| 4 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$72M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 8% |
| 5 | Consumer Staples | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Travere Therapeutics
TVTX
$5.04B
| $1.13M | ﹤0.01% |
49,960
+30
| +0.1% | +$746 |
|
527
CVS Health
CVS
$134B
| $1.12M | ﹤0.01% |
17,111
+62
| +0.4% | +$4.63K |
|
528
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $1.11M | ﹤0.01% |
35,802
+19,508
| +120% | +$660K |
|
529
iShares Global Financials ETF
IXG
$680M
| $1.11M | ﹤0.01% |
19,490
| – | – |
|
|
CLVS
530
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.07M | ﹤0.01% |
59,431
| – | – |
|
531
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $1.06M | ﹤0.01% |
20,618
-10,705
| -34% | -$552K |
|
532
Lennar Class B
LEN.B
$19.8B
| $1.06M | ﹤0.01% |
35,486
-4
| -0% | -$132 |
|
|
533
Lloyds Banking Group
LYG
$90B
| $1.04M | ﹤0.01% |
406,364
-88,598,071
| -100% | -$252M |
|
534
DuPont de Nemours
DD
$18.7B
| $1.04M | ﹤0.01% |
7,671
+521
| +7% | +$74.8K |
|
535
Lantheus
LNTH
$6.64B
| $1.04M | ﹤0.01% |
66,274
-374
| -0.6% | -$5.73K |
|
536
Trane Technologies
TT
$101B
| $1.04M | ﹤0.01% |
11,364
-748
| -6% | -$73.5K |
|
|
ADMS
537
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.04M | ﹤0.01% |
121,459
+3,342
| +3% | +$43.5K |
|
538
Northern Oil and Gas
NOG
$2.24B
| $1.01M | ﹤0.01% |
44,727
-5,015
| -10% | -$147K |
|
539
iShares Core MSCI EAFE ETF
IEFA
$191B
| $993K | ﹤0.01% |
18,050
+83
| +0.5% | +$4.87K |
|
540
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.95B
| $992K | ﹤0.01% |
39,050
+3,590
| +10% | +$89.9K |
|
|
LABL
541
DELISTED
Multi-Color Corp
LABL
| $960K | ﹤0.01% |
27,359
-250
| -0.9% | -$11.8K |
|
|
BAY
542
DELISTED
BAYER AG SPONS ADR
BAY
| $960K | ﹤0.01% |
55,477
-764,228
| -93% | -$13.2M |
|
543
Norfolk Southern
NSC
$75.1B
| $928K | ﹤0.01% |
6,207
+997
| +19% | +$164K |
|
|
544
Barclays
BCS
$93.1B
| $895K | ﹤0.01% |
124,098
-16,793,464
| -99% | -$135M |
|
545
Enanta Pharmaceuticals
ENTA
$370M
| $865K | ﹤0.01% |
12,214
| – | – |
|
546
Shinhan Financial Group
SHG
$33.4B
| $852K | ﹤0.01% |
24,000
-12,300
| -34% | -$464K |
|
547
W&T Offshore
WTI
$522M
| $843K | ﹤0.01% |
204,657
| – | – |
|
548
Lockheed Martin
LMT
$134B
| $819K | ﹤0.01% |
3,128
-888
| -22% | -$269K |
|
|
AGN
549
DELISTED
Allergan plc
AGN
| $815K | ﹤0.01% |
6,097
-32
| -0.5% | -$5.25K |
|
|
MNTA
550
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $814K | ﹤0.01% |
73,701
+8,176
| +12% | +$114K |
|
Similar funds
Fisher Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Fisher Asset Management held 954 positions worth $73.2B, down 11% from $82.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fisher Asset Management deployed $3.18B of net new capital in Q4 2018, opening 84 new positions and adding to 428 existing holdings. Its largest new stake was Weibo: 2,764,345 shares worth $162M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $422M trimmed.
- Fisher Asset Management's largest Q4 2018 buy was Weibo: 2,764,345 shares worth $162M.
- Fisher Asset Management added most to Cisco in Q4 2018, an estimated $331M increase.
- Fisher Asset Management's biggest Q4 2018 reduction was Vodafone, cutting an estimated $422M.
- Fisher Asset Management fully exited Luxottica Group in Q4 2018, selling an estimated $51M.
- Fisher Asset Management's ten largest holdings make up 26% of its $73.2B portfolio in Q4 2018.
- Fisher Asset Management opened 84 new positions and closed 88 in Q4 2018.
- Fisher Asset Management's portfolio value fell 11% quarter-over-quarter to $73.2B.
Based on Fisher Asset Management's 13F filing for Q4 2018, filed 25 Jan 2019.